Phase 3 Albumin Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS
Heart Failure; With DecompensationDiuretics Drug ReactionsAlbumin; Double
Democritus University of Thrace250 enrolled1 locationNCT06630923
Recruiting
Phase 3
Long term impact of RAS inhibition on cardio-renal outcomes: a comparative trial of angiotensin converting enzyme inhibitors, angiotensin receptor blockers or combined therapy with both agents in patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic.
Patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic.
Consorzio Mario Negri Sud2,100 enrolled1 locationACTRN12607000333415